Trials / Completed
CompletedNCT04953507
Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Pulse Oximeter
Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Thermal Radiofrequency Versus Chemical Neurolysis Using Perfusion Index Derived Pulse Oximeter
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- National Cancer Institute, Egypt · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare the efficacy of T2, T3 sympathetic block using thermal radiofrequency versus chemical neurolysis in postmastectomy pain syndrome using perfusion index derived from pulse oximetry.
Detailed description
Postmastectomy pain is a chronic pain condition with neuropathic nature. Several drugs and methods are used for its management. This study was designed to compare the efficacy of both thermal radiofrequency and chemical neurolysis in management of postmastectomy pain through using perfusion index derived from pulse oximetry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Thermal Radiofrequency | Radiofrequency lesioning at level of T2 and T3 using 80°c for 120 seconds |
| PROCEDURE | Chemical Neurolysis | injection of 1.5 ml of the chemical neurolytic agent (phenol in saline 8%) at each level |
Timeline
- Start date
- 2021-07-03
- Primary completion
- 2025-02-10
- Completion
- 2025-02-25
- First posted
- 2021-07-08
- Last updated
- 2025-07-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04953507. Inclusion in this directory is not an endorsement.